According to a new study, psoriasis patients being treated with acitretin are at greater risk of developing psychiatric disorders compared to those receiving disease-modifying antirheumatic drugs (DMARDs).
According to a new study, psoriasis patients being treated with acitretin are at greater risk of developing psychiatric disorders compared to those receiving disease-modifying antirheumatic drugs (DMARDs).